Site-specific therapy guided by a 90-gene expression assay versus empirical chemotherapy in patients with cancer of unknown primary (Fudan CUP-001): a randomised controlled trial
Article in The Lancet Oncology (July 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Application of Machine Learning in Predicting Hepatic Metastasis or Primary Site in Gastroenteropancreatic Neuroendocrine Tumors
Article in Current Oncology (October 2023)
Artificial Intelligence and Machine Learning in the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms—A Scoping Review
Article in Diagnostics (March 2022)